Hallucinogens

"Hallucinogens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.

Descriptor ID	D006213
MeSH Number(s)	D27.505.696.388 D27.505.954.427.700.372
Concept/Terms	Hallucinogens Hallucinogens Psychotomimetic Agents Agents, Psychotomimetic Hallucinogenic Agents Agents, Hallucinogenic Hallucinogenic Substances Substances, Hallucinogenic Psychedelics Psychedelic Agents Agents, Psychedelic Hallucinogenic Drugs Drugs, Hallucinogenic

Below are MeSH descriptors whose meaning is more general than "Hallucinogens".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hallucinogens [D27.505.696.388]
Therapeutic Uses [D27.505.954]
Central Nervous System Agents [D27.505.954.427]
Psychotropic Drugs [D27.505.954.427.700]
Hallucinogens [D27.505.954.427.700.372]

Below are MeSH descriptors whose meaning is more specific than "Hallucinogens".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hallucinogens" by people in this website by year, and whether "Hallucinogens" was a major or minor topic of these publications.

Bar chart showing 32 publications over 15 distinct years, with a maximum of 6 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	1	0	1
2006	2	0	2
2008	3	0	3
2009	2	0	2
2010	1	0	1
2012	1	0	1
2013	1	0	1
2016	1	0	1
2017	2	1	3
2018	1	0	1
2019	2	1	3
2020	1	0	1
2021	2	0	2
2022	4	0	4
2023	6	0	6

Below are the most recent publications written about "Hallucinogens" by people in Profiles.

Wade NE, Wallace AL, Huestis MA, Lisdahl KM, Sullivan RM, Tapert SF. Cannabis use and neurocognitive performance at 13-14 Years-Old: Optimizing assessment with hair toxicology in the Adolescent brain cognitive development (ABCD) study. Addict Behav. 2024 Mar; 150:107930.

View in: PubMed
Inan S, Ward SJ, Baltazar CT, Peruggia GA, Javed E, Nayak AP. Epicutaneous Sensitization to the Phytocannabinoid ?-Caryophyllene Induces Pruritic Inflammation. Int J Mol Sci. 2023 Sep 20; 24(18).

View in: PubMed
Loblundo C, Severa J, Peruggia GA, Black KR, Chandra S, Lata H, ElSohly M, Chapman MD, Deshpande DA, Nayak AP. Proteomics-Based Approach for Detailing the Allergenic Profile of Cannabis Chemotypes. Int J Mol Sci. 2023 Sep 11; 24(18).

View in: PubMed
Marcotte TD, Umlauf A, Grelotti DJ, Sones EG, Mastropietro KF, Suhandynata RT, Huestis MA, Grant I, Fitzgerald RL. Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial. JAMA Psychiatry. 2023 Sep 01; 80(9):914-923.

View in: PubMed
Hudzik TJ, Huestis MA, Rossi SS, Schumacher YO, Harcourt P, Budgett R, Stuart M, Tettey J, Mazzoni I, Rabin O, Danion A, Culler M, Handelsman D, Thevis M, Kinahan A. Cannabis and sport: A World Anti-Doping perspective. Addiction. 2023 11; 118(11):2040-2042.

View in: PubMed
Fitzgerald RL, Umlauf A, Hubbard JA, Hoffman MA, Sobolesky PM, Ellis SE, Grelotti DJ, Suhandynata RT, Huestis MA, Grant I, Marcotte TD. Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests. Clin Chem. 2023 07 05; 69(7):724-733.

View in: PubMed
La Maida N, Di Giorgi A, Pichini S, Busard? FP, Huestis MA. Recent challenges and trends in forensic analysis: ?9-THC isomers pharmacology, toxicology and analysis. J Pharm Biomed Anal. 2022 Oct 25; 220:114987.

View in: PubMed
Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. J Anal Toxicol. 2022 Jul 14; 46(6):e116-e185.

View in: PubMed
Wickens CM, Wright M, Mann RE, Brands B, Di Ciano P, Stoduto G, Fares A, Matheson J, George TP, Rehm J, Shuper PA, Sproule B, Samohkvalov A, Huestis MA, Le Foll B. Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2022 08 30; 118:110570.

View in: PubMed
Sempio C, Huestis MA, Kaplan B, Klawitter J, Christians U, Henthorn TK. Urinary clearance of 11-nor-9-carboxy-?9 -tetrahydrocannabinol: A detailed pharmacokinetic analysis. Drug Test Anal. 2022 Aug; 14(8):1368-1376.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement